RECURRENT STROKE IN THE WARFARIN VERSUS ASPIRIN IN REDUCED EJECTION FRACTION (WARCEF) TRIAL

BACKGROUND AND PURPOSE: WARCEF randomized 2305 patients in sinus rhythm with ejection fraction (EF) ≤35% to warfarin (INR 2.0–3.5) or aspirin 325 mg. Warfarin reduced the incident ischemic stroke (IIS) hazard rate by 48% over aspirin in a secondary analysis. The IIS rate in heart failure (HF) is too...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cerebrovasc Dis
Autors principals: Pullicino, Patrick M., Qian, Min, Sacco, Ralph L., Freudenberger, Ron, Graham, Susan, Teerlink, John R., Mann, Douglas, Di Tullio, Marco R., Ponikowski, Piotr, Lok, Dirk J., Anker, Stefan D., Lip, Gregory Y.H., Estol, Conrado J., Levin, Bruce, Mohr, J.P., Thompson, John L. P., Homma, Shunichi
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4245504/
https://ncbi.nlm.nih.gov/pubmed/25300706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000365502
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars